Den tilsvarende forbedring var 18% hos de patienter, der var blevet behandlet med placebo.
In peripheral neuropathic pain, over one third of the patients treated with Lyrica had a 50% or more improvement in pain score, compared to 18% for the patients treated with a placebo.